MediGuard App
Courtesy of Quintiles

There’s a new mobile phone app that can monitor your medications -- from pill reminders to warnings about drug interactions.

Durham-based Quintiles is providing the app for free for users of its MediGuard service.  Users can even gather information about medical research, according to this YouTube video.

Quintiles logo

The Durham-based pharmaceutical company Quintiles is acquiring a Triangle research organization. 

Quintiles announced Wednesday it reached a deal with Novella Clinical in Morrisville.  Novella is an oncology and medical device research group with nearly 300 employees in the Triangle.  The companies did not release the terms of the deal. 

New York Stock Exchange on Wall Street
Wikimedia commons

There seems to be strong investor demand on the New York Stock Exchange for North Carolina-based Quintiles.

Trading began today for the drug-testing company at $40 a share, and by mid-day – shares were up to almost $44.  The price closed at $42.

Phil Bridges, a spokesman for Quintiles, says this is an iconic moment in the company's history.

Quintiles logo

Trading on the New York Stock Exchange begins Thursday for North Carolina-based Quintiles.

The company announced late Wednesday that it is selling about 23.7 million shares of its common stock to the public at $40 a share. That would raise nearly $950 million in this initial public offering for the bio-pharmaceutical services company.

Cary-based SAS has topped the grand-daddy of Best Places to Work lists.  SAS is number one on the World’s Best Multinational Workplaces list.  To make the top 25 list – a company has to have more than five-thousand employees, with at least 40-percent of them working outside the company’s home country.  Lisa Pappas is a Customer Experience Tester at SAS.

Durham-based Quintiles has had a strong presence in China for 15 years. Now it is building a headquarters there to serve nearby Asian countries.

Leoneda Inge:  Quintiles is building a 14-million dollar regional headquarters in Shanghai. The bio-pharmaceutical services company that manages clinical trials already has a presence in Beijing and Hong Kong.  Phil Bridges is a spokesman for Quintiles.  He says it was time to significantly expand lab testing capabilities in China.